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Executive Summary Checklist 
 
Severe hypoglycemia (SH) causes significant morbidity and occasional mortality in hospitalized 
patients. The establishment of an effective program to reduce errors in the recognition and 
treatment of SH requires an implementation plan that includes the following actionable steps: 
 
¨ Establish a commitment from hospital administration and medical leadership to reduce 
SH.   
 
¨ Raise institutional awareness of the issue by comparing hospital and nursing units based 
on performance quality scorecards.  
 
¨ Create a multidisciplinary team that includes physicians, pharmacists, nurses, diabetic 
educators, medication safety officers, case managers, and long-term healthcare 
professionals. This team will:  
¨ Develop a system to identify patients receiving anti-diabetic medications 
(sulfonylureas, insulins, etc.) in the Electronic Health Record (EHR).  
¨ Implement real-time surveillance methods, analysis tools, and point-of-care 
blood glucose (BG) monitoring and reporting systems. 
¨ Create insulin order sets that could be modified to reduce risks of 
hypoglycemia. 
¨ Coordinate glucose monitoring, insulin administration, and meal delivery during 
changes of shift and times of patient transfer.  
¨ Develop a systematic approach to reduce SH and implement universal best 
practices.  
 
¨ Continuously monitor the incidence of SH in the hospital, and use the results of this 
monitoring in medical staff education sessions as a part of Continuous Quality 
Improvement (CQI).   
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The Performance Gap 
Hypoglycemia is a common problem for many patients with diabetes. Mild episodes can cause 
unpleasant symptoms and disrupt daily activities. Severe hypoglycemia (SH) can result in disorientation 
and unusual behavior, and may be life-threatening. Frequent hypoglycemia is associated with increased 
morbidity, length of stay, and mortality. Hypoglycemia has been associated with mortality in the 
intensive care units.1 Moderate and SH are strongly associated with increased risk of death, especially 
from distributive shock.2 This is by means of impairment of autonomic function, alteration of blood flow 
and composition, white cell activation, vasoconstriction, and the release of inflammatory mediators and 
cytokines.3,4 
 
The prevalence of hypoglycemia (<70 mg/dL) was reported as 5.7% of all point-of-care blood glucose 
(BG) tests in a 2009 survey of 575 hospitals.5 The definition of SH (a low BG level that requires the 
assistance of another person for recovery), is a level <40 mg/dL, has been adopted as the level likely to 
cause harm in the hospital setting.6 SH is a preventable harm. Early therapeutic management of mild 
hypoglycemia can prevent more SH episodes. In addition, literature showed that clinicians do not 
consistently adjust their patient’s anti-diabetic regimens appropriately following treatment of 
hypoglycemia, placing the patient at additional risk.7,8 
 
Causative factors that may lead to the development of hypoglycemia for inpatients may include 
excessive insulin dose, inappropriate timing of insulin or anti-diabetes therapy, unaddressed antecedent 
hypoglycemia or changes in the nutritional regimen, creatinine clearance changes, or steroid dose (9).9 
Failure of effective BG monitoring and communication between physicians, pharmacists and nurses can 
also contribute to the problem. The diverse nature of potential errors in the treatment of inpatients with 
SH supports the need for a decision-making model that can be used to predict and prevent SH episodes 
and improve overall patient safety and outcomes. 
 
Closing the performance gap will require hospitals and healthcare systems to commit to action in the 
form of specific leadership, practice, and technology plans. 
                                                       
1 Elliot M, Schafers S, McGill J, et al. Prediction and prevention of treatment-related inpatient hypoglycemia. J Diabetes Sci 
Technol 2012;6(2):302-309. 
2 The NICE-SUGAR Study Investigators. Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012;367:1108-
1118. 
3 Adler GK, Bonyhay I, Failing H, et al. Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for 
rigorous glycemic control. Diabetes 2009;58:360-366. 
4 Wrogjt RJ, Frier BM. Vascular disease and diabetes: is hypoglycemia an aggravating factor? Diabetes Metab Res Rev 
2008;24:353-363. 
5 Swanson CM, Potter DJ, Kongable GL, et al. Update on inpatient glycemic control in hospitals in the United States. Endocr Pract 
2011;17(6):853-861. 
6 Schwartz AV, Vittinghoff E, Sellmeyer DE, et al. Diabetes-related complications, glycemic control, and falls in older adults. 
Diabetes Care 2008;31(3):391-396. 
7 Boucai L, Southern WN, Zonszein J. Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. Am J 
Med 2011;124(11):1028-1035. 
8 DiNardo M, Noschese M, Korytkowski M, et al. The medical emergency team and rapid response system; finding, treating, and 
preventing hypoglycemia. Jt Comm J Qual Patient Saf 2006;32(10):591-595. 
9 Deal EN, Liu A, Wise LL, et al. Inpatient insulin orders: Are patients getting what is prescribed? J Hosp Med 2011;6(9):526-529. 
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Leadership Plan 
• The plan must include the fundamentals of change outlined in the National Quality Forum safe 
practices, including awareness, accountability, ability, and action.10 
• Hospital governance and senior administrative leadership (medical, pharmacy, and nursing) must 
fully understand the performance gaps in their own healthcare system. 
• Hospital governance, senior administrative leadership, and clinical/safety leadership must close 
their own performance gaps by implementing a comprehensive approach. 
• Hospitals should set a goal date for the implementation of the corrective plan, with measurable 
quality indicators and milestones. 
• Specific budget allocations for the plan should be evaluated by governance boards and senior 
administrative leaders. 
• Clinical/safety leadership should endorse the plan and ensure implementation across all 
providers and systems. 
Practice Plan 
• Each hospital should create a multidisciplinary team, which includes physicians, pharmacists, 
nurses, diabetic educators, medication safety officers, case managers, and long-term healthcare 
professionals). 
• Develop a systematic approach to reducing severe hypoglycemia: 
o Identify events and prioritize 
o Raise institutional awareness 
§ Compare hospitals and nursing units based on performance quality scorecards 
(use harm rate for at-risk patient days: # of events/# of patient days during 
hospital stay when a diabetic agent is ordered at any time) 
o Encourage nurses to enter hypoglycemia into safety event self-reporting site 
o Communicate to the hospital leadership board 
o Send letters to physicians and providers (from case managers) 
o Educate hospital staff, providers and patients – hospital newsletter and posters made for 
each hospital/nursing unit listing known and assumed solutions to hypoglycemia (e.g., 
“STOP Hypoglycemia!”) 
o Kickoff reception for safety initiative 
• Implement foundational Best Practices and “Just Do Its” (Appendices A and B) 
o Establish a Hypoglycemia Task Force for the hospital 
o Propose multidisciplinary diabetes safety team at each hospital  
o Adopt foundational best practices (literature-based recommendations for all hospitals) 
o Implement “Just Do Its!” (or “Start Nows”) – these should be safe and reasonable 
interventions tested internally  
o Adopt ISMP recommendations for U-500 insulin precautions (Appendix C) 
• Event investigation and collect causative factors 
o Causative Factors (to consider as part of analysis tool): 
§ Insulin stacking 
§ Wrong drug, dose, route, patient, or time 
§ Insufficient glucose monitoring 
§ Basal heavy regimen 
                                                       
10 NQF Safe Practices for Healthcare. 2010 Update. 
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§ Decreased nutritional intake 
§ Event related to outpatient or emergency department drug administration 
§ Event while treating elevated potassium 
§ Glucose trend not recognized 
§ High dose sliding scale insulin 
§ Home regimen continued as inpatient 
§ Significant reduction in steroid dose 
§ Sulfonylurea-related hypoglycemia 
§ Insulin administration and food intake not synchronized 
§ POC glucose reading not linked to insulin administration 
§ POC glucose reading not synchronized with food intake 
o Analysis tool forms reviewed by either pharmacist and/or nurse in a timely manner (e.g., 
72 hours) for causative factors; communicate findings with physician(s) 
o Results are collated and reported to Medication Safety Committee and the Pharmacy 
and Therapeutics Committee 
o Identify interventions (evidence-based and expert opinion) that are used to resolve the 
most common or most harmful causative factors 
o Track the interventions and create customized action plans based on an integrated 
results dashboard 
o Share best practices within hospital and to other hospitals 
• Share strategies and implement informed interventions on target floors and patients. 
Technology Plan 
Suggested practices and technologies are limited to those proven to show benefit or are the only known 
technologies with a particular capability. As other options may exist, please send information on any 
additional technologies, along with appropriate evidence, to info@patientsafetysummit.org. 
 
• Implement real-time surveillance method for informatics alerts: “High-Risk Sulfonylurea Alert” 
and “Hypoglycemia Risk Alert”. 
• Implement an automated hypoglycemia event analysis tool (to discover local causes of 
hypoglycemia and guide future interventions). 
• Implement point-of-care BG monitoring and reporting systems, including quality assurance 
reports to audit compliance with hypoglycemia management goals and restriction of insulin 
utilization. 
• Implement automated triggers for most common causative factors of hypoglycemia, an 
electronic tracking system for SH events, interventions used and clinical outcomes. 
• Implement a results dashboard for each nursing unit within the hospital and Best Practices used 
to resolve the hypoglycemic event(s). 
• Set restrictions for the prescribing of U-500 Regular Insulin to only specialists and under special 
circumstances in CPOE. 
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System or Practice Available Technology 
 
ONC Meaningful Use Certified EHR system Electronic 
Health Record (EHR) System with the following 
capabilities:  
• Computerized Physician Order Entry (CPOE) 
• Drug-drug interaction check 
• Drug-allergy interaction check 
• Clinical Decision Support tools (CDS) 
 
The following EHR vendors have signed 
the Patient Safety Movement Open Data 
Pledge:11 
• Cerner 
• GE Healthcare 
 
CPOE simulation tool to quantify the risk of serious ADEs 
with your current system CPOE12,13 
• Leapfrog CPOE Evaluation 
Tool14 
 
Drug Libraries • Alaris® 
• Baxter® 
• Hospira® 
• Fresenius® 
• B.Braun® I.V. pumps 
• BD Intelliport™ Medication 
Management System for I.V. 
injectables, or  
• comparable systems. 
 
Pharmacy Workflow Manager • DoseEdge® from Baxter 
Healthcare® 
 
 
Workgroup 
Chair: 
OPEN 
Co-Leaders: 
Ron Jordan, RPh, FAPhA, Dean, Chapman University School of Pharmacy 
Jerika Lam, PharmD, AAHIVP, FCSHP, Assistant Professor, Chapman University School of Pharmacy 
                                                       
11 EHR companies that have signed Patient Safety Movement Open Data Pledge 
12 Leung AA, Keohane C, Lipsitz S, Zimlichman E, Amato M, Simon SR, Coffey M, Kaufman N, Cadet B, Schiff G, Seger DL, Bates 
DW. Relationship between medication event rates and the Leapfrog computerized physician order entry evaluation tool. J Am Med 
Inform Assoc. 2013 Jun;20(e1):e85-90. 
13 Metzger J, Welebob E, Bates DW, Lipsitz S, Classen DC. Mixed results in the safety performance of computerized physician 
order entry. Health Aff (Millwood). 2010 Apr;29(4):655-63. 
14 https://leapfroghospitalsurvey.org/cpoe-evaluation-tool/ 
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Appendix A: Summary of Foundational Best Practices15 
Intervention Rationale 
Elevate awareness of hypoglycemia Best in class and individual hospital initiatives to elevate 
awareness on preventable harm have improved patient care. 
Real time analysis (48 hours) Pharmacy surveillance system provides information of when and 
where these events occur, but not why they occur. Many hospitals 
have had success lowering harm rate using this intervention. 
Create and utilize diabetes 
management team 
AACE/ADA (American Association of Clinical 
Endocrinologists/American Diabetes Association) noted creation 
of a multidisciplinary steering committee guided by local diabetic 
experts can establish reasonable and achievable glycemic 
management goals. 
Provide prescriber with tools to use 
as a dosing guide 
• AACE/ADA suggests a systems approach for management of 
inpatient glycemic control. 
• Can establish reasonable and achievable glycemic 
management goals with use of protocols and order sets. 
Nursing education process • AACE/ADA noted a lack of ownership in diabetes care may be 
due in part to insufficient knowledge or confidence in 
diabetes management. 
• Improvements in care can be achieved by ongoing education 
and training. 
Insulin dose timing coincide with 
food intake 
• AACE/ADA noted many hospitals are challenged by poor 
coordination of meal delivery and prandial insulin 
administration. 
• A systems approach can promote the coordination of glucose 
monitoring, insulin administration, and meal delivery, 
particularly during change of shifts and times of patient 
transfer. 
Improve POC glucose testing with 
the insulin administration time 
• AACE/ADA stated that bedside BG monitoring with use of 
POC glucose meters should be performed before meals and 
at bedtime in most inpatients who are eating usual meals. 
• Important to avoid routine use of correction insulin at 
bedtime. 
Utilize glucose management 
software 
Collective evidence showed a reduction in hypoglycemic events 
through the use of glucose software management 
                                                       
15 Moghissi ES, et al. American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement 
on Inpatient Glycemic Control. Diabetes Care 2009;32(6):1119-1131. 
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Appendix B: Just Do Its! Recommendations16 
 
 
 
Just Do It! 
Modify insulin order set to hold insulin only with MD order 
Modify insulin order set to match pending electronic order set to reduce doses of 
bedtime sliding scale (30% reduction) 
Modify insulin order set to avoid routine correction insulin at specific times (e.g., 
0200 and 0400) 
Modify insulin order set to match pending electronic order set to state: Notify MD 
when hypoglycemic event occurs (2 levels <70 mg/dL or 1 level <50 mg/dL, or 
>300 mg/dL) 
Add Pharmacist and Endocrinologist on diabetes management team 
Appendix C: Start Now: U-500 Regular Insulin Project16 
Scope:  Develop guidelines for injectable U-500 insulin to reduce ADE preventable harm. U-500 insulin is 
an uncommon concentration, which if given with syringes designed for U-100 insulin can cause serious 
harm. 
Preventable Harm:  Risk potential and risk severity are both high 
Resources:  Pharmacist(s) and nurse(s) 
Deliverable Goals:  
• Develop standard High Alert or High Hazard Medication or restrictions for U-500 insulin at all 
hospitals to prevent improper dosing and harm secondary to hypoglycemia. 
• Develop policy that will safeguard or restrict the use of U-500 to specialists and special 
circumstances 
Risks/Barriers:  
• Hospitals that do not have the drug on formulary have not addressed patients using drug from 
home; 
• Hospitals feel drug not on formulary will protect them from ADEs (Non-formulary does not equal 
no-risk of ADE) 
	
 
                                                       
16 Milligan P, Blackburn C, Dachroeden R. Multi-faceted improvement initiative to detect and improve prevention of severe 
hypoglycemia. ASHP Summer Meeting 2014. 
